Improved health-related quality of life after cardioneuroablation in patients with vasovagal syncope

Baysal E., Mutluer F. O., Dagsali A. E., Kumrulu U. C., Huang H. D., Aksu T.

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Publication Date: 2022
  • Doi Number: 10.1007/s10840-022-01420-9
  • Journal Name: JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Keywords: Syncope, Ablation, Neurocardiogenic syncope, Pacemaker, Vasovagal syncope, Bradycardia, RECURRENCE
  • Marmara University Affiliated: Yes

Abstract

Background As the most common cause of syncope, vasovagal syncope (VVS) is mediated by parasympathetic overactivity and/or sympathetic withdrawal. Although catheter ablation of ganglionated plexi or cardioneuroablation has been used to treat VVS, its role in quality of life (QoL) has not been formally evaluated. The aim of this study was to demonstrate if this novel treatment results in improvement QoL of patients with VVS.